SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " effect " 2,322 found 🔀 AI-powered Shuffle
Career coach recommends 4-hour burnout-proof job application routine
A career coach advises job seekers against spending all day applying to jobs. She says a four-hour routine is burnout-proof and more effective.
Costs of Iran war will linger despite conflict's end, experts say
The effects of the war and other factors driving inflation are likely to stick around for months, experts say, presenting an ongoing challenge to American households.
NH businesses feel impact of low summer hiring rates
A new report from the New Hampshire Fiscal Policy Institute shows summer hiring rates are lower than previous years in the Granite State, and two businesses on Hampton Beach are feeling the effects.
The sky is not falling. Americans are getting healthier.
Despite declining obesity and heart disease rates, increasing cancer survival rates, and a record high life expectancy, politicians from both parties are pushing costly and ineffective policies to …
FISU reinforces its commitment to the World University Sports Movement
On the second day of the meeting, the Executive Committee focused on the upcoming Universiades and the future of the FISU Forum. After a first day concentrating on updating statutes and strategies for a simpler, more innovative and effective future, FISU’s Executive Committee focused on upcoming events on this second and last day of their […]
New vitamin B12 therapy shows promise against deadly brain cancer
Researchers have identified a vitamin B12–based compound that can cross the blood-brain barrier and home in on glioblastoma tumors. In animal studies, the compound accumulated preferentially in tumor tissue and delivered sustained nitric oxide directly to cancer cells. It also worked synergistically with existing glioblastoma treatments, significantly enhancing their tumor-fighting effects.
How to use AI in your dating life responsibly and effectively
Whether you love or loathe generative AI chatbots, they’re becoming increasingly involved in the business of romance.
ICE mask ban takes effect in N.Y. amid dueling lawsuits and a race for governor
The Trump administration’s lawsuit argues that states do not have the authority to regulate the federal government’s operations.
Prediction market Kalshi sues Illinois over its push to regulate sports bets
Prediction market Kalshi sued Illinois on Tuesday, seeking to block new taxes and license requirements set to take effect July 1.
David Glew to Lead Cameron School of Business as Interim Dean
The University of North Carolina Wilmington has selected David Glew to serve as interim dean of the Cameron School of Business, effective July 1.
Texas school board to vote on required Bible readings in public education
If approved by the Texas State Board of Education, which is controlled by Republicans, the reading list would take effect in 2030.
West Knoxville business closing as Tennessee tightens hemp regulations
The Hemp House in West Knoxville will close by July 2 as Tennessee’s new hemp regulations take effect.
It's Xbox's turn (again), as console prices keep going up
Microsoft announced a price hike for the Xbox Series consoles today, the third in little over a year. Effective August 1, the Xbox Series S, which launched in 2020 for $300, will cost $500 in the U.S. The Xbox Series X, which launched in 2020 at $500, will go for $800. This follows a round of PlayStation 5 price increases from Sony this spring, and a slow-motion increase for Nintendo’s Switch 2, which will kick in in the U.S. in September. (Mind you, there were also eight video game industry price hikes in six months of 2025). The chart up top shows the sudden ascent of console prices over the past year, a sudden surge in an already unusual hardware generation. Prices had been flat for years, now “up” is the new “flat.” Game console prices used to go down across the length of a console generation, but not this time around. Microsoft’s explanation for the new price hike today: We hoped another price increase would not be necessary, and we have spent the last several months working with suppliers on options. Unfortunately, console storage and memory prices have increased by more than 2.5x and we expect another doubling by the fall of 2027. The entire consumer electronics industry is struggling with the current components crisis, but the effects are particularly hard on consoles. Unlike phones, computers, speakers, and other consumer devices, consoles are typically not sold at a profit, but instead for less than they cost to make. This is an issue well beyond game consoles. Apple announced price hikes on its computers and tablets today as well. Game File is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe Item 2: Brutal Bungie cuts Bungie laid off “most” of its Destiny development team and some developers who worked on Marathon, the newest game from the struggling Sony-owned studio. A WARN notice issued by Sony to Washington State, where Bungie is based, tallied cuts impacting 292 workers, effective next month. That’s strictly for Bungie/Sony jobs in Washington and wouldn’t account for any elsewhere. The video I clipped below shows the redacted list of Bungie cuts filed to Washington State officials. As you’ll see, I had to scroll for a while… In a note emailed to PlayStation workers and published online, PlayStation game studios chief Hermen Hulst offered the following explanation for these latest cuts at Bungie: This is painful news, especially for talented colleagues whose roles have been eliminated. This decision was made only after extensive discussion and careful consideration, and I want to provide some context on how we arrived here. Over the past several months, together with Bungie leadership, we reviewed the studio’s long-term direction, development priorities, resource needs, and role within our broader portfolio strategy. We explored multiple alternatives before concluding that a reduction was necessary to align the studio’s resources with its current priorities and long-term goals. In 2022, Sony bought Bungie for $3.7 billion. The studio’s marquee game, the multiplayer live service shooter Destiny 2 was losing popularity at the time. Its next game Marathon, released earlier this year, has been well-reviewed but had a slow start. Bungie is renowned for making great shooter games, and Destiny fans have mourned the wind-down of Destiny 2. They’ve also expressed bewilderment over reports that Destiny 3 is not, per Bloomberg, immediately in the cards.
Serious statin side effects on muscles are extremely rare, new research confirms
Scientists created a new tool to help doctors predict a patient’s risk of severe muscle problems from taking a statin.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Ormond Beach businesses push drivers to slow down on Granada Boulevard
Downtown Ormond Beach businesses are taking matters into their own hands after drivers continue to ignore a reduced speed limit on Granada Boulevard — nearly a year after the change took effect.
Takeaways: Supreme Court hands Trump massive wins on immigration agenda
The Supreme Court’s conservative majority delivered President Donald Trump a pair of significant affirmations of his immigration policy Thursday, paving the way for the administration to effectively remove more than 1 million people from the US and keep many others from entering in the first place.
UT Health San Antonio identifies the first potential probiotic treatment for lupus
Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO, June 25, 2026 – Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, found a link between a bacterium in the gut microbiome, or ecosystem, and lupus, which could lead to more effective […]
Fed Rule Effectively Puts Automaker Polestar Out Of Business In The U.S.
Volvo’s upscale electrified division pulls the proverbial plug on future U.S. sales because of its ties to China.
Updated XBOX Console Prices
Effective August 1, 2026, the price of XBOX consoles will be increasing by US$100 for 512 GB models and US$150 for 1 TB models.
Major part of student-loan repayment overhaul is blocked in court
A federal court ruled that the Education Department's proposed borrowing caps for advanced healthcare programs cannot take effect on July 1.
Lane County Public Health to slash jobs as it weathers federal healthcare cuts
Lane County’s Public Health Department announced significant budget reductions as federal healthcare cuts approved by Congress in the so-called Big Beautiful Bill, or H.R.1, go into effect.
FDA-approved drug may finally help immunotherapy defeat rare liver cancer
Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping them in nearby fibrous tissue. An FDA-approved drug called AMD3100 freed those T cells to attack the cancer, significantly improving the effectiveness of immunotherapy in tumor samples.
Paranovus Entertainment Technology Limited Announces 1-For-100 Reverse Share Split
NEW YORK, NY / ACCESS Newswire / June 25, 2026 / Paranovus Entertainment Technology Limited (NASDAQ:PAVS) ("we" or the "Company"), today announced that it will effect a reverse share split of its outstanding Class A ordinary shares, par value $0.000012 ...
Utah State Joins Mountain Pacific Sports Federation as Affiliate Member in Indoor Track & Field
LOGAN, Utah – Utah State has accepted an invitation to join the Mountain Pacific Sports Federation as an affiliate member in men's and women's indoor track & field, it was announced by the conference on Thursday. Utah State's membership in the conference will be effective on July 1.
Who gets to decide Colorado’s economic future?
By Sarah Blackhurst Colorado’s prosperity depends on industries that grow our food, build our future and power our homes. But today, these sectors face an invisible threat from 5,000 miles away: the European Union’s Corporate Sustainability Due Diligence Directive (CS3D). This foreign regulation requires companies to mitigate environmental and human-rights effects throughout their entire global […]
Federal judge bars Trump from implementing proof of citizenship requirement to vote
The ruling by U.S. District Court Judge Denise Casper in Boston effectively converts a preliminary injunction she issued a year ago, in which she temporarily blocked many of Trump’s efforts to overhaul elections, into a permanent ban.
Online violence against women in politics: what shapes political party responses to technology-facilitated gender-based violence?
Political parties have a primary role to play in tackling online violence against women and gender diverse politicians. While the prevalence and impact of TFGBV, such as coordinated disinformation campaigns, deepfake image-based sexual abuse or trolling are well documented, many parties are still building their knowledge on how to respond effectively and have not put in place internal practices and policies that respond to the rapidly evolving, poorly regulated digital ecosystem. About the ReportIn order to promote and protect fair and democratic participation in politics, this ALIGN Report explores what political parties are doing in response to TFGBV and what factors shape their action. The findings, based on existing literature and interviews with gender and politics professionals, indicate there are three sets of factors which donors, civil society and practitioners should consider when designing action to support political parties to respond to TFGBV internally. These are: (1) gender norms; (2) socio-political environment; and (3) internal party factors.Key messagesUnequal gender norms are ubiquitous across politics, shaping expectations of leaders to be strong and assertive, and practices of political parties to uphold masculinist values and sustain cultures of silence. These often lead to weak response to TFGBV against women politicians.The socio-political context can incentivise or disincentivise action, depending on the salience of gender issues, which are increasingly weaponised. Electoral competitiveness, domestic laws (i.e. quota requirements), and even the political system or global normative frameworks influence political will to act.Internal party factors that shape responses will vary across countries and contexts, but include: structures to enforce codes of conduct, policies and reporting mechanisms on (TF)GBV, political ideology, extent of centralisation of leadership, and crucially the meaningful participation of women in decision-making positions, not least through internal women’s wings.Party responses can be seen as a spectrum, with actions falling between active discouragement to address TFGBV to commitment to transform unequal norms and practices within the party.About the ToolkitTogether with the report, this ALIGN toolkit offers gender professionals and others working on democratic strengthening a set of guiding questions and reflection prompts to identify which responses could be most effective and suitable in different contexts. These actions can complement other solutions to TFGBV, such as regulations promoting safety by design. The assessment spans a broad range of factors including: (1) different manifestations of gender norms, (2) the socio-political environment and (3) internal party structures.Key messagesPolitical parties are duty-bound to take action internally to respond to the significant threats posed to women members and candidates, including from their own party colleagues, affiliates and political peers.Existing party approaches to TFGBV can be assessed along a spectrum which ranges from active discouragement and passive acceptance to minimal response and transformative change.To generate effective and context-appropriate solutions to TFGBV, it is important to consider how gender norms shape leadership expectations and internal party practices, while also analysing the impact of the socio-political environment. While actions to support women to stay safe online are very common, codes of conduct and measures to strengthen women’s voice and power in the parties are proposed as most transformative solutions.
The 'pet effect' and how animals may boost your health
Whether you’re the proud pet parent to an animal with paws, claws, hooves or fins, it’s no secret how much joy and companionship they bring us.
Primaries prove it: In New York, pro-Israel politics are now a liability
All of Mayor Zohran Mamdani's congressional picks won in Tuesday’s primaries. And they all campaigned on cracking down on the Jewish state
Overwatch Fans Revolt Over New Skins That Cost Too Damn Much
The new ‘Ultra’ skins include visual and audio effects, but is that enough?
Megan McKnight named director of Health Promotion and Wellness at Penn State
Megan McKnight brings extensive experience in health promotion, prevention education and student well-being initiatives to her new role as director of Health Promotion and Wellness at Penn State, effective June 29.
German Business Outlook Improves Slightly as Uncertainty Wanes
Germany’s business outlook brightened slightly in June, easing worries about the knock-on effects of the Iran war on Europe’s largest economy.
Dean Simon Sheather to retire after transformative tenure at UK Gatton College of Business and Economics
After more than three decades in higher education — and nearly eight years of transformative leadership at the University of Kentucky — Simon Sheather, Ph.D., will retire as dean of the Gatton College of Business and Economics, effective June 26.
UK heatwave: Red extreme heat warning to take effect
The warning, which means there could be a risk to life, will be in force in parts of England and Wales from 09:00.
Most IVF ‘add-on’ treatments have no effect on fertility or remain unproven, study says
Review shows majority of procedures offered alongside standard IVF not backed by reliable evidence
KC promised a World Cup economic boost. But not for every business, leaders say
As some businesses question the World Cup’s effect on the Kansas City economy, local officials and event organizers say they still expect a boost for the city.
12 Things Health Agencies Need to Know About Enterprise AI
Learn how Minnesota's health agency is effectively adopting AI tools for public health work.
Johnson County cancer survivor's business helping others got her two tickets to the World Cup
The Balm Box include items like blankets, underarm pillows, cuticle oil, and lip balm — products designed to address the real side effects of cancer treatment.
Hahn can lead Boise State University, Idaho business into the future
To ensure continued success, we must have effective education institutions with strong leadership at the helm. | Opinion
Harrington chosen as Charlotte's interim mayor
Harrington replaces Vi Lyles, who stepped down as mayor effective June 30 in early May.
National Family Planning & Reproductive Health Association et al. v. Robert F. Kennedy, Jr. et al.
The National Family Planning & Reproductive Health Association (NFPRHA) and its member, the Family Health Council of Central Pennsylvania (FHCCP), sued the Trump administration to protect the integrity of the Title X family planning program. Title X is the country’s only dedicated federal program for family planning services. For more than 55 years, the program has provided access to effective contraceptive methods, cancer screenings, testing and treatment for STIs, and other preventive services, with priority given to patients with low incomes.
The Leadership Advantage Hidden Inside Effective Business Plans
Business plans can give entrepreneurs an edge as they launch a business. But you have to write them the right way.
Deepak Adwani Promoted to Executive Director of Miraj Entertainment Ltd.
Miraj Entertainment Ltd. has announced the promotion of Deepak Adwani from Vice President – P&L to Executive Director of Miraj Cinemas, effective immediately. This announcement comes in the wake of the untimely passing of Managing Director Bhuvanesh Mendiratta, and marks the next chapter in Miraj Cinemas’ journey. Adwani brings over two decades of experience in […]
A common vitamin could help fight one of the deadliest brain cancers
A clinical trial is exploring whether high doses of vitamin B3 could give patients with glioblastoma a better chance against the aggressive brain cancer. Scientists found that niacin may help revive immune cells that tumors shut down, allowing them to attack cancer more effectively. Early results have been promising, with patients showing significantly better progression-free survival than expected.
KSU master’s graduates benefit from NIH-funded bridge program
Recent Kennesaw State University graduate April Ford engaged in a program designed to help master’s students in the College of Science and Mathematics gain the experience they needed to pursue doctoral degrees elsewhere. She’ll stand as an example of the Peach State Bridges to the Doctorate program’s effectiveness, having earned her Master of Science in Integrative Biology (MSIB) and acceptance into a Ph.D. program. Ford, Jojo Croffie, and Lindsey Knight all earned their MSIB degrees, and thanks to enrichment through the Peach State Bridges to the Doctorate program, each will start a Ph.D. in the fall.
Opinion: Michigan has policy options to help curb online betting addiction
More than five years into legal sports betting, it is time for a fresh look at how Michigan regulates the industry and addresses the ripple effects on public health.
Why shadows on a tennis court cause headaches for players and fans
Every year at some tournaments, stadium design and the sun combine to dazzling effect — in a bad way.
CVS Pharmacy® expands GLP-1 support to lower costs, improve access, and help patients stay on therapy
New $50 monthly copay for eligible Medicare patients, one-on-one pharmacist guidance, and over-the-counter products to help manage common side effects available to support patients
California is getting ready to increase a health insurance tax. Will it affect your premium?
A family of four could pay $400 more a year in premiums — but the tax still needs federal approval from the Trump administration to take effect.
Business People: More high-level changes at Target
RETAIL Target Corp., Minneapolis, announced it has hired Grant McGee as executive vice president and chief legal and compliance officer, effective May 31, and Jeff England as chief supply chain and logistics officer to accelerate our…
One common fat may fuel type 2 diabetes while another helps fight it
Not all fats affect your body the same way. Researchers found that palmitic acid, a saturated fat common in many foods, may contribute to insulin resistance and type 2 diabetes by triggering inflammation, toxic fat buildup, and cellular stress. In contrast, oleic acid—the heart-healthy fat abundant in olive oil—appears to help protect insulin function and may even counter some of the harmful effects of palmitic acid.
Ezekiel Emanuel: My father lived into his 90s. He understood something many successful men miss
The wellness industry wants you obsessing over biomarkers and supplements. One physician's life offers a simpler—and more effective—blueprint for aging.
Science & Medicine: A San Antonio researcher is studying magnets and money to treat alcohol use disorder
Alcohol use disorder affects millions of Americans, but treatment options remain limited, and relapse is common. A UT Health San Antonio researcher is studying two unconventional approaches that he hopes could one day be combined into a single, more effective treatment.
Want to Slow Your Aging? Multivitamins, Diet, and Fitness May Help
Recent research has explored the possible effects of diet, daily multivitamins, and cardiorespiratory fitness on aging. Learn about the findings here.
Save up to $300 with these early Prime Day Apple deals
Prime Day 2026 kicks off on Tuesday, but there are numerous Apple deals in effect now that deliver the lowest prices of the season.
Scientists found a cannabis compound that relieves pain without the high
Compounds responsible for the aroma of cannabis and many other plants may offer a surprising new way to relieve chronic pain. Researchers found that several cannabis-derived terpenes significantly reduced pain in mouse models of fibromyalgia and post-surgical pain, with one terpene, geraniol, showing especially strong effects. Unlike THC, these compounds are not associated with psychoactive effects, making them a potentially attractive alternative for pain treatment.
Sugar-Free Diets May Have a Hidden Side Effect, Study in Mice Suggests
But there's a lot we don't know.
Sugar-Free Diets May Have a Hidden Side Effect, Study in Mice Suggests
But there's a lot we don't know.
Ozempic changed obesity treatment, but experts say the real revolution is next
The obesity treatment landscape is changing fast, with GLP-1 drugs opening the door to more effective care than ever before. Experts now envision a future where medications, minimally invasive procedures, surgery, and precision medicine work together to deliver better long-term results.
The Yoga Effect: The Science-Backed Benefits
Researchers are now finding yoga may help everything from chronic pain to mental health, to heart function.
Chichester tyre business banned over 'fire risks'
Twyford Recycling's operating permit has been removed with immediate effect.
Israel–Hezbollah ceasefire becomes first test of Trump Iran framework after talks delay
A U.S.-backed ceasefire between Israel and Hezbollah was set to take effect Friday as talks with Iran scheduled for Switzerland were abruptly postponed.
Apple Explains Why watchOS 27 Drops Support for So Many Models
Apple today detailed why five Apple Watch models will miss out on watchOS 27 and the new Siri AI features that come with it. The Apple Watch Series 6, 7, 8, SE 2, and the original Apple Watch Ultra will not receive watchOS 27, and will only get basic security updates going forward. With the update, Apple is effectively dropping three years' worth of device support in a single software update, which is unprecedented for the product line.
Einstein’s “biggest blunder” may finally have an explanation
Scientists have uncovered a surprising connection between quantum gravity and an exotic quantum state of matter that could explain why the universe isn’t expanding wildly fast. The study suggests that the very shape of space-time may protect the cosmological constant from disruptive quantum effects.
Perceptive Capital Solutions Corp and Freenome Announce Effectiveness of Registration Statement for Proposed Business Combination
/PRNewswire/ -- Perceptive Capital Solutions Corp ("PCSC") (Nasdaq: PCSC), a special purpose acquisition company ("SPAC") sponsored by an affiliate of...
Bayer Welcomes Kacy Perry as New Country Division Head for Crop Science Canada
CALGARY, Alberta, June 18, 2026--The Crop Science division of Bayer announced that Kacy Perry has been appointed the Country Division Head (CDH) for Crop Science Canada, effective July 1. In this role, she will lead 550+ employees working at multiple sites across Canada and serves as a member of Bayer’s North American Leadership Team for Crop Science.
CMS Ignores the Law (Again) – This Time Taking Health Insurance Away from Individuals with Substance Use Disorders, Mental Health Conditions, and Serious Health Conditions
Just a few weeks ago, we explained how the Center for Medicare and Medicaid’s (CMS) proposed regulation on state directed payments goes far beyond the statutory authority in H.R. 1 to incredibly harmful effect. Now it has happened again. This time CMS has issued an interim final rule on work reporting requirements (the “IFR”) that […]
“Shocking and surreal”: What scientists witnessed in the Arctic defies belief - Futura-Sciences
Frontline of Global Warming: The Arctic’s Alarming Transformation The Arctic sits front and center in the battle against climate change—and Svalbard, a Norwegian archipelago at the heart of the region, is feeling its effects more drastically than anywhere else on Earth. In fact, this polar territory is warming six to...
Titan Alum Tam Nguyen to Lead Center for Family Business
President of Advance Beauty College and Cal State Fullerton business alum Tam Nguyen ’05 (MBA) will be the director of the CSUF Center for Family Business, effective July 1. For more than a decade, Nguyen has been involved in the center through teaching, speaking and outreach capacities. Nguyen taught the Family Business Dynamics course from […]
Sullivan to lead basic and preclinical science at Duke School of Medicine
Beth A. Sullivan, PhD, has been appointed vice dean for basic and preclinical science at Duke University School of Medicine, effective July 1, 2026.
7 unexpected takeaways from the newest research on cannabis and brain effects
Whether it’s used in adolescence, midlife or older age may make a big difference.
Zero sugar, more problems? Study reveals surprising gut health effects
A study presented at ENDO 2026 suggests that completely eliminating sugar from a low-fat diet may harm gut health and increase inflammation.
More than 11K bottles of blood pressure drug recalled
Certain lots of a popular diuretic have been recalled due to concerns about the drug's effectiveness.
Rumble Announces Realignment into Two Core Business Units and Renames Newly Acquired Cloud And AI-Infrastructure Business “Quake AI”
Post-merger, Rumble Cloud Renamed Quake AI, Integrating Northern Data Offerings Rumble to Remain the Video and Media Platform’s Core Brand Name Corporate Parent to be Renamed RUM Group Inc. and Will Oversee Two Business Units: Rumble and Quake AI LONGBOAT KEY, Fla., June 17, 2026 (GLOBE NEWSWIRE) -- Rumble (NASDAQ: RUM) today introduced a new business unit and legal name for the company following the closing of its acquisition of Northern Data AG (“Northern Data”). Effective June 18, 2026, under
AI for discovery science and healthcare delivery
AI's effect on scientific R&D and healthcare delivery and how policy can support further innovation and responsible growth.
Climate advocacy by scientists shows mixed effects, no clear trust boost or backlash
Scientists have become more visible in climate debates, engaging in public communication, policy advice, open letters, political demonstrations and even civil disobedience. Scientists who speak out on ...
Georgia Republicans backtrack on redistricting plans
After Gov. Brian Kemp called them into a special session, state lawmakers said they didn’t have enough time to draw new maps that would have taken effect for the 2028 elections.
Georgia Republican leaders nix redistricting plans amid pushback
Republican leaders feared the issue would give Democrats an effective issue to campaign on during the midterms.
Ozempic and Wegovy linked to surprising drop in violent behavior
A Rutgers study suggests GLP-1 drugs such as Ozempic and Wegovy may weaken the link between impulsive tendencies and violent behavior. The surprising finding hints that these medications could affect how people act on impulses, though researchers stress that cause and effect have not been proven.
Best Life: The yoga effect: The science-back benefits
June 21st marks the International Day of Yoga, a practice that started thousands of years ago in ancient India and today, it’s not just about stretching or relaxing.
How Trump sidelined national security experts ahead of his war with Iran
Worried about a president who seemed to be flying by the seat of his pants as he waged war, Congress stepped in to establish a council of experts to advise the president, gathering information from across the government to consider the consequences and effects of military action.
Chronotherapy considerations in lithium treatment for bipolar disorder
Nature Mental Health - In this Perspective, Ray and colleagues review 50 years of studies on the effectiveness and toxicity of lithium and argue that its effects depend on dosing time. They propose...
WHO Step-by-Step programme recognized as a promising innovation for mental health in humanitarian settings
WHO, in collaboration with the Pan American Health Organization (PAHO) and Lebanon’s National Mental Health Programme, showcased Step-by-Step at the World Bank Group’s biennial Fragility Forum in Washington, DC. The forum convened more than 1500 representatives from governments, international organizations and civil society to advance the development agenda in the world’s most fragile and crisis-affected communities. WHO was invited to demonstrate Step-by-Step – a digital self-help intervention for depression, alongside innovations presented by Stanford University and Google. The World Bank Group selected Step-by-Step from among more than 50 innovations that they reviewed in the lead up to the Forum.About Step-by-StepStep-by-Step is a free digital tool developed by WHO in collaboration with Lebanon’s National Mental Health Programme and other partners, that helps people manage depression and anxiety on their own, with light guidance from a trained supporter. It uses a picture-based story to walk users through evidence-based techniques for managing common mental health conditions. Users complete five modules, with weekly contacts – of around 15 minutes each – from a trained non-specialist helper, such as a community health worker.Evidence-basedClinical trials in Lebanon involving nearly 1250 participants – including 680 Lebanese participants and 569 Syrian participants – showed that Step-by-Step significantly reduced depression, anxiety and stress, and improved daily functioning. By the end of the programme, a reduction in depressive symptoms of more than 50% was reported by almost half (46%) of Lebanese participants and more than one third (37%) of Syrian participants compared to approximately 14% of those who did not use the programme. Cost-effectiveness analyses further suggest that Step-by-Step may offer a cost-saving response to depression in humanitarian emergencies in low- and middle-income countries.Used globallyStep-by-Step is already in use nationwide in Lebanon and Thailand, as part of each country’s mental health system. In India, the NGO – Kaya Guides – has adapted Step-by-Step for delivery through a widely used messaging app. Together, these programmes have provided thousands of people with evidence-based support for depression. The content is freely available from the WHO website for any organization or country to adapt for their own context.A new implementation guideThe Fragility Forum coincided with the recent launch of WHO’s new practical guide: Psychological self-help interventions: delivering self-help for individuals, featuring Step-by-Step and Doing What Matters in Times of Stress (WHO, 2026). The guide is designed to help governments, health workers, organizations and planners bring evidence-based mental health support to more people, particularly in low-resource and crisis-affected settings.
CMS proposes codifying, strengthening Medicare drug price negotiations
Presented by Philip Morris International{beacon} Health Care Health Care PRESENTED BY The Big Story Protect Our Care highlights adverse effects of GOP cuts on hospitalsDemocratic-…
Apple plans to change its Hide My Email privacy feature that could make it less effective
In the coming weeks, Apple will move anonymously generated emails addresses to a different domain.
MSU announces naming of Greene College of Science & Engineering, cementing eastern Kentucky family legacy
Morehead State University is honored to announce the naming of the Greene College of Science & Engineering in recognition of a significant and generous gift from Drs. Randy (Class of 1967) and Judy Greene. Approved by the MSU Board of Regents at the meeting on June 12, the college naming will take effect on July 1. A formal recognition and transition will occur later in the year. To learn more about the College of Science & Engineering and its programs, email dsci@moreheadstate.edu or call 606-783-2626. For more information on the Greene Family Scholarship Endowment, or to establish your own, contact MSU’s Office of Alumni Relations & Development at 606-783-2033 or email giving@moreheadstate.edu.
KERRIGAN IN THE WASHINGTON TIMES: Virginia Should Not Tax Away its Data Center Advantage - Small Business & Entrepreneurship Council
“However it is framed, the practical effect would reach far beyond one industry. A tax on digital infrastructure is a tax on everyone, including working families, local governments and small businesses in every corner of Virginia.” In a June 15 Washington Times Op-ed, SBE Council President & CEO Karen Kerrigan documents the state of Virginia’s tech […]
Political contribution limits in Oregon take effect in January — but it’s unclear if election officials will
Three months after lawmakers provided more guidance and funding for the law's rollout, there are still several major unknowns.
Prediction markets are opening many new opportunities for unregulated insider trading and unethical bets – in the name of making a game out of politics
The rapidly growing popularity of prediction markets is sparking worries about the markets’ effects on US politics, where campaign staff has bet on its candidate’s electoral performance.
The darts business scores with the Luke Littler effect
A cottage industry run by family companies is attracting private equity as it expands globally
Scientists just found a hidden weakness in forever chemicals
Researchers discovered that hydrogen radicals generated by intense UV light can break down stubborn PFAS “forever chemicals” without added chemicals. The breakthrough reveals a key mechanism that could lead to greener and more effective technologies for permanently destroying these pollutants.
UC wins $3.3M grant to study microplastics' effects on cardiovascular health
Microplastics are in the food people eat, the water they drink and the air they breathe. UC researchers are studying the impact microplastics have on the heart.
AMS Science Preview: 30-Day Forecasts? Little Ice Age, wave-dampening hurricanes
The latest AMS journals research discusses the possibility of 30-day weather forecasts, whether the Little Ice Age was caused by depopulation of the Americas, the cooling effects of multi-year La Nina…
Adobe rolls out major Creative Cloud updates for Lightroom, Premiere, more
Adobe is rolling out a broad set of Creative Cloud updates this week, introducing new AI-powered tools and workflow improvements.
Xbox Game Studios boss Craig Duncan steps down
The head of Xbox Game Studios Craig Duncan has stepped down after more than 18 months in the role. Duncan replaced former Studios boss Alan Hartman in November 2024, and oversaw Halo Studios, The Coalition, Flight Sim, Turn 10, Playground Games, Rare, Obsidian, Ninja Theory, Compulsion Games, The Initiative, Double Fine, InXile, Undead Labs, World’s Edge and XGS Publishing. He departs the organization this week. His studios will report to Xbox Chief Content Officer Matt Booty until a replacement is found. Duncan has been part of the Xbox organization since 2011 and is best known for running highly regarded UK developer Rare for nearly 14 years. He oversaw the developer’s Kinect and Sea of Thieves eras. Prior to that, he held various senior roles at Codemasters, Midway and Sumo Digital, and worked cross titles such as Sonic and Sega All-Stars Racing, Wheelman and Colin McRae. He's also VP of the charity SpecialEffect. Subscribe Meanwhile, Xbox Game Studios chief of staff Louise O’Connor will also be leaving the company. O’Connor joined Rare in 1999 beginning as an animator on cult favourite N64 game Conker’s Bad Fur Day. She’s worked in numerous art and production roles at the UK studio, and even won an AIAS award for voicing the character Leafos in Viva Piñata. She left Rare following the cancellation of Everwild in 2025, before becoming chief of staff in September that year. In an email to staff, Duncan wrote: “When I stepped into the role of leading XGS 20 months ago, my purpose was to serve our studios, our teams, and the people making our games. Together, we set out to deliver high-quality games, strengthen the cultural fabric across our studios, and help shape the future of the business. I’m proud to say we delivered many flawless launches that drove business success for the company.” On O’Connor, he added: “Louise has been a thoughtful, creative, and trusted partner who has consistently championed the craft and supported our studios with clarity and care. I’m grateful for everything she’s brought to XGS, and I’m sure she’ll be successful in whatever comes next for her.”
Xbox Game Studios boss Craig Duncan steps down
The head of Xbox Game Studios Craig Duncan has stepped down after more than 18 months in the role. Duncan replaced former Studios boss Alan Hartman in November 2024, and oversaw Halo Studios, The Coalition, Flight Sim, Turn 10, Playground Games, Rare, Obsidian, Ninja Theory, Compulsion Games, The Initiative, Double Fine, InXile, Undead Labs, World’s Edge and XGS Publishing. He departs the organization this week. His studios will report to Xbox Chief Content Officer Matt Booty until a replacement is found. Duncan has been part of the Xbox organization since 2011 and is best known for running highly regarded UK developer Rare for nearly 14 years. He oversaw the developer’s Kinect and Sea of Thieves eras. Prior to that, he held various senior roles at Codemasters, Midway and Sumo Digital, and worked cross titles such as Sonic and Sega All-Stars Racing, Wheelman and Colin McRae. He's also VP of the charity SpecialEffect. Subscribe Meanwhile, Xbox Game Studios chief of staff Louise O’Connor will also be leaving the company. O’Connor joined Rare in 1999 beginning as an animator on cult favourite N64 game Conker’s Bad Fur Day. She’s worked in numerous art and production roles at the UK studio, and even won an AIAS award for voicing the character Leafos in Viva Piñata. She left Rare following the cancellation of Everwild in 2025, before becoming chief of staff in September that year. In an email to staff, Duncan wrote: “When I stepped into the role of leading XGS 20 months ago, my purpose was to serve our studios, our teams, and the people making our games. Together, we set out to deliver high-quality games, strengthen the cultural fabric across our studios, and help shape the future of the business. I’m proud to say we delivered many flawless launches that drove business success for the company.” On O’Connor, he added: “Louise has been a thoughtful, creative, and trusted partner who has consistently championed the craft and supported our studios with clarity and care. I’m grateful for everything she’s brought to XGS, and I’m sure she’ll be successful in whatever comes next for her.”
Why Marketing Feels Harder as Your Business Grows by Nathan Tayloe
At some point, most growing businesses hit the same moment. What used to feel straightforward starts to feel more complicated. Marketing takes more effort. Results feel less predictable. What once worked consistently begins delivering mixed outcomes. It is easy to assume something is broken. In many cases, nothing is. The business has simply reached a different stage. What Worked Before Starts to Lose Its Edge Early on, growth is often driven by a few things working well at the same time: Referrals are strong The value of the offering is clear The team is aligned Decisions are made quickly Marketing, in that stage, tends to feel easier because the business itself is easier to understand. As the company grows, that simplicity fades. The audience expands. Services evolve. New people join the team. More channels are added. More decisions are made across more touchpoints. Marketing is no longer communicating one clear story. It is trying to represent a more complex business. Complexity Creates Friction That added complexity does not always show up immediately. It builds over time. Messaging starts to drift. Different parts of the business describe what they do in slightly different ways. The website no longer reflects how the company actually operates. Sales conversations evolve faster than the brand. At the same time, more activity is introduced to try to keep growth moving: New campaigns More content Additional platforms More tools and reporting The volume increases. The clarity does not always keep pace. That is when marketing starts to feel harder. It’s Not a Lack of Effort Most teams respond to this stage by doing more. More output More meetings More adjustments More experimentation That effort is not misplaced. It is often pointed in the wrong direction. When the underlying issue is a lack of alignment, more activity tends to create more noise. Results become harder to interpret. Decisions take longer. Progress feels inconsistent. From the outside, everything looks active. From the inside, it feels less certain. The Real Shift As businesses grow, marketing becomes less about execution and more about alignment. The companies that navigate this transition well tend to refocus on a few fundamentals: A clearly defined audience A strong, consistent position in the market Messaging that reflects how the business actually operates Alignment between leadership, marketing, and sales When those elements are in place, execution becomes more effective again. Marketing does not necessarily become easier, but it becomes more consistent. A Different Kind of Discipline Growth introduces more opportunity, but it also demands more discipline. What worked when the business was smaller often cannot be scaled without adjustment. The systems, messaging, and decision-making that once felt intuitive need to become more intentional. That is not a sign of failure. It is a normal part of growth. Marketing feels harder because the business has become more complex. The solution is not to outwork that complexity. It is to bring clarity to it. The companies that do that well tend to regain momentum quickly. Those who do not often stay busy without seeing the same level of progress. — Learn more about how we help organizations align strategy, brand, and execution. Visit tayloegray.com, or reach out directly at nathan@tayloegray.com.